A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Newly added devices include a new LimaCorporate should component, US approval of the Incraft aneurysm stent graft and a first-in-class newborn-screening diagnostic.
Nine novel device or indication approvals were added to Medtech Insight's Approvals Tracker last week, including approvals in China, Australia, Europe and the US.
On Nov. 30, Italian firm Limacorporate SPA announced the CE mark and global launch of its SMR TT Hybrid...